Antisense Oligonucleotide-Based Therapy of Viral Infections
Nucleic acid-based therapeutics have demonstrated their efficacy in the treatment of various diseases and vaccine development. Antisense oligonucleotide (ASO) technology exploits a single-strand short oligonucleotide to either cause target RNA degradation or sterically block the binding of cellular...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2021-11-01
|
| Schriftenreihe: | Pharmaceutics |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1999-4923/13/12/2015 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|